What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK in Q3 2026?

42 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK for Q3 2026. Use the holders table for investor-level position and value details.

Corvus Pharmaceuticals, Inc. - COMMON STOCK (CRVS)

CUSIP: 221015100

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / COMMON STOCK
Total 13F shares: 4,596,184
Total 13F value: $52,959,119
Share change: +1,044,691
SEC-reported price per share: $11.52
Number of holders: 42
Value change: +$11,849,055
Number of buys: 18
Number of sells: 14
Shares outstanding: 84,416,811

Security key

221015100

Report period

Q3 2026

Institutions

Top holders

CRVS full security history Ownership snapshot Full 13F holder table Corvus Pharmaceuticals, Inc. SEC filings Corvus Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 221015100

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

6/15

Latest evidence

30 Jun 2026

13F 13D/G 3/4/5 Lead comparable stake: 10% 9 rows are not safely comparable across share classes. 13D/G row: ORBIMED ADVISORS LLC Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 10%.

6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 5

ORBIMED ADVISORS LLC 10%

Richard A. Miller MD 7.8%

BlackRock, Inc. 7.5%

Sirenia Capital Management LP 7.5%

STATE STREET CORP 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F 13D/G 3/4/5 Company · Director, 10%+ Owner 13F 13D/G 3/4/5	10% Reported 13D/G · 23 Jan 2026	$107,045,190 7,165,006 shares	—	30 Jun 2026
Richard A. Miller MD	13D/G 3/4/5 Richard A. Miller · President and CEO, Director 13D/G 3/4/5	7.8% Reported 13D/G · 31 Dec 2025	$40,653,959 6,085,922 shares	+$5,781,901	31 Dec 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	7.5% Reported 13D/G · 30 Jun 2026	$106,653,837 7,138,811 shares	—	30 Jun 2026
Sirenia Capital Management LP	13D/G 13D/G	7.5% Reported 13D/G · 31 Mar 2026	$101,657,601 6,831,828 shares	$0	31 Mar 2026
STATE STREET CORP	13D/G 13F STATE STREET CORPORATION · Company 13D/G 13F	5.3% Reported 13D/G · 30 Jun 2026	$71,943,383 4,474,091 shares	$0	30 Jun 2026
ADAMS STREET PARTNERS LLC	13F 13D/G 3/4/5 Company · 10%+ Owner 13F 13D/G 3/4/5	3.9% Reported 13D/G · 23 Jan 2026	$48,937,703 3,275,616 shares	—	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

4,596,184

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

172

Q3 2026 holders

Holder diff

-130

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend